Assignee
MAYNE PHARMA LLC
US·5 granted patents·5 pending applications·0 citations·filing 2016–2025
Top patents by PatentIndex Score
10 records- 0183US12350255B2Stabilized oxymetazoline formulations and their usesMAYNE PHARMA LLC·Filed 2022·Granted Jul 8, 2025·0 cites·17 claims
- 0283US2026076913A1Stabilized microcapsules, method of their preparation and uses thereofMAYNE PHARMA LLC·Filed 2025·Application pending·0 cites
- 0382US2026097016A1Stabilized oxymetazoline formulations and their usesMAYNE PHARMA LLC·Filed 2025·Application pending·0 cites
- 0469US12491163B2Stabilized microcapsules, method of their preparation and uses thereofMAYNE PHARMA LLC·Filed 2021·Granted Dec 9, 2025·0 cites·15 claims
- 0567US2025339394A1Compositions comprising encapsulated tretinoinMAYNE PHARMA LLC·Filed 2025·Application pending·0 cites
- 0656US12589100B2Halobetasol foam composition and method of manufacture thereofMAYNE PHARMA LLC·Filed 2019·Granted Mar 31, 2026·0 cites·3 claims
- 0754US2020352892A1Topical foam compositionMAYNE PHARMA LLC·Filed 2020·Application pending·0 cites
- 0853US11020407B2Corticosteroid containing foam compositions and method of manufacture thereofMAYNE PHARMA LLC·Filed 2016·Granted Jun 1, 2021·0 cites·11 claims
- 0952US2019365783A1Halobetasol foam composition and method of manufacture thereofMAYNE PHARMA LLC·Filed 2019·Application pending·0 cites
- 1046US10857159B2Halobetasol foam composition and method of use thereofMAYNE PHARMA LLC·Filed 2016·Granted Dec 8, 2020·0 cites·4 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →